ERBB2 and breast cancer: The human epidermal growth factor receptor 2 (HER-2) status and proliferation marker protein Ki-67 levels are two crucial factors in determining the treatment strategy for BC patients (Yerushalmi et al., 2010; Loibl and Gianni, 2017).